First Trust Direct Indexing’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-14,435
Closed -$4.65M 46
2024
Q3
$4.65M Buy
14,435
+1,354
+10% +$443K 0.25% 74
2024
Q2
$4.09M Buy
13,081
+2,905
+29% +$853K 0.25% 78
2024
Q1
$2.89M Buy
10,176
+1,184
+13% +$346K 0.22% 90
2023
Q4
$2.59M Buy
8,992
+1,621
+22% +$442K 0.23% 90
2023
Q3
$1.98M Buy
7,371
+790
+12% +$197K 0.23% 93
2023
Q2
$1.46M Buy
6,581
+154
+2% +$35.7K 0.16% 140
2023
Q1
$1.55M Sell
6,427
-1,244
-16% -$305K 0.18% 128
2022
Q4
$2.01M Buy
7,671
+291
+4% +$78K 0.27% 87
2022
Q3
$1.66M Buy
7,380
+905
+14% +$219K 0.24% 92
2022
Q2
$1.57M Buy
6,475
+388
+6% +$95.1K 0.22% 106
2022
Q1
$1.47M Buy
6,087
+1,927
+46% +$443K 0.18% 130
2021
Q4
$936K Sell
4,160
-55
-1% -$11.6K 0.12% 200
2021
Q3
$896K Buy
4,215
+34
+0.8% +$7.83K 0.13% 202
2021
Q2
$1.02M Buy
4,181
+96
+2% +$23.6K 0.15% 170
2021
Q1
$1.02M Buy
4,085
+414
+11% +$98.8K 0.27% 89
2020
Q4
$844K Buy
+3,671
New +$846K 0.23% 106

Other funds holding AMGN

First Trust Direct Indexing's AMGN Position: Q4 2024 in Review

First Trust Direct Indexing sold out of Amgen (AMGN) in Q4 2024, closing a stake of 14,435 shares — an estimated $4.65M sold.

First Trust Direct Indexing first reported a position in AMGN in Q4 2020 and held it in 16 quarters. The position peaked at $4.65M in Q3 2024. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • First Trust Direct Indexing reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
  • First Trust Direct Indexing sold 14,435 Amgen shares in Q4 2024, an estimated $4.65M.
  • First Trust Direct Indexing first reported a position in Amgen in Q4 2020 and held it in 16 quarters.
  • First Trust Direct Indexing's Amgen position peaked at $4.65M in Q3 2024.
  • 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on First Trust Direct Indexing's 13F filing for Q4 2024.